Daewon Pharmaceutical Co., Ltd. - ROE
003220.KS
Price:
$7710
Market Cap:
$165.25B
Established in 1958 and headquartered in Seoul, South Korea, Daewon Pharmaceutical Co., Ltd. is a well-regarded pharmaceutical enterprise specializing in the development, manufacturing, and distribution of a comprehensive range of medications and medical supplies within the South Korean market. Its extensive product portfolio targets diverse therapeutic fields, encompassing cardiovascular, respiratory, anti-infective, oncology, and neuropsychiatric conditions. Key offerings include Oramin-F Soft Cap, a notable multivitamin; Pelubi Tablet, an NSAID specifically formulated for pain management; Freefol-MCT Inj., a microemulsion propofol designed to prevent exogenous bacterial infections; Megex-...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2005-09-29
Stock Exchange
KSC
Ticker
003220.KS
PE Ratio
[8.98]
ROE
[1.00%]
Current Ratio
[1.12]
Dividend Yield
[3.24%]
Enterprise Value
[330.67B]
Dividend History
The ROE as of August 2026 (TTM) for Daewon Pharmaceutical Co., Ltd. (003220.KS) is 1.00%
According to Daewon Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 1.00%. This represents a change of 439.28% compared to the average of 0.19% of the last 4 quarters.
Daewon Pharmaceutical Co., Ltd. (003220.KS) Historical ROE (quarterly & annually)
How has 003220.KS ROE performed in the past?
The mean historical ROE of Daewon Pharmaceutical Co., Ltd. over the last ten years is 8.30%. The current 1.00% ROE has changed -87.95% with respect to the historical average. Over the past ten years (40 quarters), 003220.KS's ROE was at its highest in in the September 2017 quarter at 5.24%. The ROE was at its lowest in in the September 2025 quarter at -6.80%.
Average
8.30%
Median
8.62%
Minimum
-0.52%
Maximum
13.32%
Daewon Pharmaceutical Co., Ltd. (003220.KS) ROE by Quarter and Year
Discovering the peaks and valleys of Daewon Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 299.43%
Maximum Annual ROE = 13.32%
Minimum Annual Increase = -110.05%
Minimum Annual ROE = -0.52%
| Year | ROE | Change |
|---|---|---|
| 2025 | -0.52% | -110.05% |
| 2024 | 5.16% | -42.55% |
| 2023 | 8.98% | -29.42% |
| 2022 | 12.73% | 299.43% |
| 2021 | 3.19% | -61.35% |
| 2020 | 8.25% | -38.08% |
| 2019 | 13.32% | 2.91% |
| 2018 | 12.94% | 102.34% |
| 2017 | 6.39% | -49.01% |
| 2016 | 12.54% | 5.03% |
Daewon Pharmaceutical Co., Ltd. (003220.KS) Average ROE
How has 003220.KS ROE performed in the past?
The current ROE of Daewon Pharmaceutical Co., Ltd. (003220.KS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.54%
5-year avg
5.91%
10-year avg
8.30%
Daewon Pharmaceutical Co., Ltd. (003220.KS) ROE vs. Peers
How is 003220.KS’s ROE compared to its peers?
Daewon Pharmaceutical Co., Ltd.’s ROE is less than Korea United Pharm Inc. (16.62%), less than CMG Pharmaceutical Co., Ltd. (2.83%), less than Suheung Co., Ltd. (7.87%), less than Boditech Med Inc. (11.34%), less than Samjin Pharmaceuticals Co., Ltd. (8.22%), less than Jeil Pharmaceutical Co.,Ltd (4.46%), less than Ilyang Pharmaceutical Co.,Ltd (6.99%), less than JW Holdings Corporation (31.34%), less than Kwang Dong Pharmaceutical Co., Ltd. (3.45%), greater than BNC Korea Co., Ltd. (-1.39%),
| Company | ROE | Market cap |
|---|---|---|
| 16.62% | $258.65B | |
| 2.83% | $81.76B | |
| 7.87% | $250.56B | |
| 11.34% | $218.16B | |
| 8.22% | $225.31B | |
| 4.46% | $145.43B | |
| 6.99% | $148.78B | |
| 31.34% | $277.11B | |
| 3.45% | $295.48B | |
| -1.39% | $163.46B |
Build a custom stock screener for Daewon Pharmaceutical Co., Ltd. (003220.KS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Daewon Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Daewon Pharmaceutical Co., Ltd. (003220.KS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Daewon Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Daewon Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Daewon Pharmaceutical Co., Ltd. (003220.KS)?
What is the highest ROE for Daewon Pharmaceutical Co., Ltd. (003220.KS)?
What is the 3-year average ROE for Daewon Pharmaceutical Co., Ltd. (003220.KS)?
What is the 5-year average ROE for Daewon Pharmaceutical Co., Ltd. (003220.KS)?
How does the current ROE for Daewon Pharmaceutical Co., Ltd. (003220.KS) compare to its historical average?